What should I do if I am unable to scan the test stick while performing the BD Veritor™️ At-Home COVID-19* Test?

The Scanwell® App requires access to your camera in order to complete this step. Please ensure you have enabled camera access for the Scanwell® App in your smartphone settings.

Find a clean, flat, non-reflective working surface indoors with bright and even lighting. Window light is preferable, but avoid harsh light and nearby shadows. Do not test outside. Clean your camera lens, and make sure the entire scan card is visible on your screen when scanning. The test stick should be placed in the center of the scan card within the outline. Daylight is preferable for testing. If using household light, you should be close to, but not directly underneath, the light. If you continue to have issues, try moving to another room.
Overhead or ceiling lights can cause shadows. Your camera can detect faint shadows that you may not see. If you experience persistent issues, move to a different room or try switching off any overhead or ceiling lighting and use a desk lamp instead. You may need to move the scan card and test stick away from intensely bright lights due to glare.
The Scanwell® App will provide feedback to help you complete the scan. Please refer to the onscreen instructions for more information on how to successfully perform the scan. The test stick cannot be analyzed after the 5 minute scanning timer and analyzing the test stick after the 5 minute scanning timer can lead to inaccurate test results. If you are still unable to complete this step despite following the instructions, please call the BD Customer Care team at 844-4-VERITOR (844-483-7486) for more information on what to do next.

*This product has not been FDA cleared or approved, but has been authorized by FDA under an Emergency Use Authorization. This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.